$861.27+15.26% · 3M
Moving avg
1W-0.96%
1M+8.15%
3M+13.24%
6M-7.86%
YTD+4.59%
1Y+27.82%
3Y+96.64%
5Y+330.74%
52-week range
$637.0062% of range$999.00
Company health
Value4/6
Growth3/6
Profitability2/6
Health3/6
Dividend4/6
Bull vs bear
Strengths
- Analysts see 16% upside to a $999 target
- Analyst consensus is "Buy"
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$100.84B
Enterprise value
$103.09B
P/E ratio (TTM)
21.76x
P/S ratio (TTM)
0.24x
EV/EBITDA
14.69x
Per share & returns
EPS (TTM)
$39.00
Dividend yield
0.39%
Beta (1Y)
0.32
30-day change
+8.15%
Trading
Volume (24h)
334.62K
Previous close
$878.73
Shares outstanding
117.08M
About McKesson Corporation
Sector
Healthcare
Industry
Medical - Distribution
Exchange
NYSE
Symbol
MCK
McKesson Corporation is a large-cap healthcare company in the Medical - Distribution industry. Its shares are listed on NYSE (United States) and trade under the ticker MCK.
Frequently asked questions
What is McKesson Corporation's market cap?
McKesson Corporation (MCK) has a market capitalization of $100.84B.
What is McKesson Corporation's P/E ratio?
McKesson Corporation trades at a price-to-earnings (P/E) ratio of 21.76.
What exchange does MCK trade on?
MCK trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap